Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Pfreundschuh M, Trümper L, Österborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006;7(5):379–391.
   PubMedGoogle Scholar
• Canalis E, Mazziotti G, Giustina A, et al. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18(10):1319–1328.
   PubMed Web of Science ®Google Scholar
• Weinstein RS. Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med. 2011;365(1):62–70.
   PubMed Web of Science ®Google Scholar
• Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018;61(1):7–16.
   PubMed Web of Science ®Google Scholar
• Stava CJ, Jimenez C, Hu MI, et al. Skeletal sequelae of cancer and cancer treatment. J Cancer Surviv. 2009;3(2):75–88.
   PubMed Web of Science ®Google Scholar
• Rana T, Chakrabarti A, Freeman M, et al. Doxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFβ. PLoS One. 2013;8(10):e78043.
   PubMed Web of Science ®Google Scholar
• Guzon-Illescas O, Perez Fernandez E, Crespí Villarias N, et al. Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J Orthop Surg Res. 2019;14(1):203.
   PubMed Web of Science ®Google Scholar
• Oleksik AM, Ewing S, Shen W, et al. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. Osteoporos Int. 2005;16(8):861–870.
   PubMed Web of Science ®Google Scholar
• International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329(14):987–994.
   PubMed Web of Science ®Google Scholar
• Ziepert M, Hasenclever D, Kuhnt E, et al. Standard international prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. J Clin Oncol. 2010;28(14):2373–2380.
   PubMed Web of Science ®Google Scholar
• Cabanillas ME, Lu H, Fang S, et al. Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures. Leuk Lymphoma. 2007;48(8):1514–1521.
   PubMed Web of Science ®Google Scholar
• Svendsen P, Shekhrajka N, Nielsen KL, et al. R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients. Leuk Lymphoma. 2017;58(5):1105–1113.
   PubMed Web of Science ®Google Scholar
• Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367(9527):2010–2018.
   PubMed Web of Science ®Google Scholar
• Chun KJ. Bone densitometry. Semin Nucl Med. 2011;41(3):220–228.
   PubMed Web of Science ®Google Scholar
• Glüer CC. 30years of DXA technology innovations. Bone. 2017;104:7–12.
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Pooler BD, Lauder T, et al. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med. 2013;158(8):588.
   PubMed Web of Science ®Google Scholar
• Poeschel V, Held G, Ziepert M, et al. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Lancet. 2019;394(10216):2271–2281.
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Lee LJ, Muñoz Del Rio A, et al. Simultaneous screening for osteoporosis at CT colonography: Bone mineral density assessment using MDCT attenuation techniques compared with the DXA reference standard. J Bone Miner Res. 2011;26(9):2194–2203.
   PubMed Web of Science ®Google Scholar
• Schreiber JJ, Anderson PA, Rosas HG, et al. Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management. J Bone Jt Surg - Ser A. 2011;93(11):1057–1063.
   PubMed Web of Science ®Google Scholar
• Marinova M, Edon B, Wolter K, et al. Use of routine thoracic and abdominal computed tomography scans for assessing bone mineral density and detecting osteoporosis. Curr Med Res Opin. 2015;31(10):1871–1881.
   PubMed Web of Science ®Google Scholar
• Christensen DL, Nappo KE, Wolfe JA, et al. Proximal femur hounsfield units on CT colonoscopy correlate with dual-energy X-ray absorptiometry. Clin Orthop Relat Res. 2019;477(4):850–860.
   PubMed Web of Science ®Google Scholar
• Christensen DL, Nappo KE, Wolfe JA, et al. Ten-year fracture risk predicted by proximal femur hounsfield units. Osteoporos Int. 2020;31(11):2123–2130.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, Oden A, et al. Risk of hip fracture according to the world health organization criteria for osteopenia and osteoporosis. Bone. 2000;27(5):585–590.
   PubMed Web of Science ®Google Scholar
• Van Staa TP, Leufkens HGM, Abenhaim L, et al. Oral corticosteroids and fracture risk: Relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39(12):1383–1389.
   PubMed Web of Science ®Google Scholar
• De Vries F, Bracke M, Leufkens HGM, et al. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. 2007;56(1):208–214.
   PubMed Web of Science ®Google Scholar
• Proctor DN, Melton LJ, Khosla S, et al. Relative influence of physical activity, muscle mass and strength on bone density. Osteoporos Int. 2000;11(11):944–952.
   PubMed Web of Science ®Google Scholar
• Booth S, Plaschkes H, Kirkwood AA, et al. Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma. Blood Adv. 2020;4(18):4337–4346.
   PubMed Web of Science ®Google Scholar
• Berenson AB, Breitkopf CR, Grady JJ, et al. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol. 2004;103(5 Pt 1):899–906.
   PubMed Web of Science ®Google Scholar
• Brown JE, Ellis SP, Silcocks P, et al. Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma. Clin Cancer Res. 2006;12(21):6480–6486.
   PubMed Web of Science ®Google Scholar
• Pfeilschifter JJ, Diel IJ. Osteoporosis due to cancer treatment: Pathogenesis and management. J Clin Oncol. 2000;18(7):1570–1593.
   PubMed Web of Science ®Google Scholar
• Rizzoli R, Body JJ, Brandi ML, et al. Cancer-associated bone disease. Osteoporos Int. 2013;24(12):2929–2953.
   PubMed Web of Science ®Google Scholar
• Jonat W, Kaufmann M, Sauerbrei W, et al. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: the Zoladex Early Breast Cancer Research Association Study. J Clin Oncol. 2002;20(24):4628–4635.
   PubMed Web of Science ®Google Scholar
• Gralow JR, Biermann JS, Farooki A, et al. NCCN Task Force report: bone health in cancer care. J Natl Compr Cancer Netw. 2009;11 Suppl 3:S1–S50.
   Google Scholar
• Bittenbring JT, Neumann F, Altmann B, et al. Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. J Clin Oncol. 2014;32(29):3242–3248.
   PubMed Web of Science ®Google Scholar
• Lim HK, Ha H Il, Park SY, et al. Comparison of the diagnostic performance of CT hounsfield unit histogram analysis and dual-energy X-ray absorptiometry in predicting osteoporosis of the femur. Eur Radiol. 2019;29(4):1831–1840.
   PubMed Web of Science ®Google Scholar
• Lee S, Chung CK, Oh SH, et al. Correlation between bone mineral density measured by dual-energy X-ray absorptiometry and hounsfield units measured by diagnostic CT in lumbar spine. J Korean Neurosurg Soc. 2013;54(5):384.
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Bodeen G, Brett A, et al. Comparison of femoral neck BMD evaluation obtained using lunar DXA and QCT with asynchronous calibration from CT colonography. J Clin Densitom. 2015;18(1):5–12.
   PubMed Web of Science ®Google Scholar
• Ziemlewicz TJ, Maciejewski A, Binkley N, et al. Opportunistic quantitative CT bone mineral density measurement at the proximal femur using routine contrast-enhanced scans: direct comparison with DXA in 355 adults. J Bone Miner Res. 2016;31(10):1835–1840.
   PubMed Web of Science ®Google Scholar
• Gausden EB, Nwachukwu BU, Schreiber JJ, et al. Opportunistic use of CT imaging for osteoporosis screening and bone density assessment: a qualitative systematic review. J Bone Joint Surg Am. 2017;99(18):1580–1590. Vol
   PubMed Web of Science ®Google Scholar
• Hendrickson NR, Pickhardt PJ, Del Rio AM, et al. Bone mineral density T-scores derived from CT attenuation numbers (hounsfield units): clinical utility and correlation with dual-energy X-ray absorptiometry. Iowa Orthop J. 2018;38:25–31.
   PubMedGoogle Scholar
• Lenchik L, Weaver AA, Ward RJ, et al. Opportunistic screening for osteoporosis using computed tomography: state of the art and argument for paradigm shift. Curr Rheumatol Rep. 2018;20(12):74.
   PubMed Web of Science ®Google Scholar
• Buckley L, Guyatt G, Fink HA, et al. 2017 American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2017;69(8):1095–1110.
   PubMed Web of Science ®Google Scholar
• Westin JR, Thompson MA, Cataldo VD, et al. Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. Clin Lymphoma, Myeloma Leuk. 2013;13(2):99–105.
   PubMed Web of Science ®Google Scholar
• Paccou J, Merlusca L, Henry-Desailly I, et al. Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study. Ann Oncol. 2014;25(2):481–486.
   PubMed Web of Science ®Google Scholar